Search results
Results from the WOW.Com Content Network
[3] [14] [16] This is further complicated by high rates of treatment dropout and substance relapse in studies of treatment in this population. [3] [17] Research has focused on two major forms of treatment for those with comorbid SUD and PTSD: treatments that focus on the traumatic experience(s), and treatments that do focus on traumatic ...
The National Comorbidity Survey: Reinterview (NCS-2) was a follow-up study conducted between 2001 and 2002. The participants in NCS-1 were re-interviewed with the aim to collect information about changes in mental disorders, substance use disorders , and the predictors and consequences of these changes over the ten years between the two surveys.
North Bethesda, Maryland: National Institute on Drug Abuse. 26 May 2020; School-Based Drug Abuse Prevention: Promising and Successful Programs (PDF). Ottawa, Ontario: Public Safety Canada. 31 January 2018. ISBN 978-1-100-12181-9. Archived (PDF) from the original on 19 May 2021
Dual diagnosis (also called co-occurring disorders (COD) or dual pathology) [1] [2] is the condition of having a mental illness and a comorbid substance use disorder.There is considerable debate surrounding the appropriateness of using a single category for a heterogeneous group of individuals with complex needs and a varied range of problems.
The division of comorbidity as per syndromal and nosological principles is mainly preliminary and inaccurate, however it allows us to understand that comorbidity can be connected to a singular cause or common mechanisms of pathogenesis of the conditions, which sometimes explains the similarity in their clinical aspects, which makes it difficult ...
Substance use, also known as drug use, is a patterned use of a substance (drug) in which the user consumes the substance in amounts or with methods which are harmful to themselves or others. The drugs used are often associated with levels of substance intoxication that alter judgment, perception, attention and physical control, not related with ...
These comorbidities may be so severe that the costs and risks of cancer treatment would outweigh its short-term benefit. Since patients often do not know how severe their conditions are, nurses were originally supposed to review a patient's chart and determine whether a particular condition was present in order to calculate the index.
In medicine, the Comorbidity–polypharmacy score (CPS) is a measure of overall severity of comorbidities. [1] It is defined as the simple sum of the number of known comorbidities (concurrent conditions) and pre-admission medications taken by the patient ( polypharmacy ), as a surrogate for the “intensity” of the comorbidities.